ISSN: 1347-9032

Journal Home

Cancer Science Q1 Unclaimed

Wiley-Blackwell United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Science is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 150. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2025 €. The scope of the journal is focused on oncology, cancer research, palliative care, radiotherapy. It has an SJR impact factor of 1.587 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.587.

Cancer Science focuses its scope in these topics and keywords: factor, cancer, growth, immune, patients, epidermal, cells, targets, breast, tumor, ...

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Medicine (miscellaneous) (Q1) Oncology (Q1)

Price

2025 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1.587

SJR Impact factor

150

H Index

456

Total Docs (Last Year)

1158

Total Docs (3 years)

18944

Total Refs

7663

Total Cites (3 years)

1152

Citable Docs (3 years)

6.36

Cites/Doc (2 years)

41.54

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Clinical Oncology Q1
Annals of Oncology Q1
Annual Review of Public Health Q1
The Lancet Global Health Q1
Nature Reviews Disease Primers Q1

Compare this journals

Aims and Scope

Best articles by citations

Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer

Combination immunotherapy with radiation and CpG-based tumor vaccination for the eradication of radio- and immuno-resistant lung carcinoma cells

Molecular mechanisms of transforming growth factor-beta signaling and disease: The 59th Fujihara International Seminar, 2010

Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs

Body iron stores and breast cancer risk in female atomic bomb survivors

Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma

Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells

Development of a risk prediction model for lung cancer: The Japan Public Health Center-based Prospective Study

Oxysterol binding protein-related protein-5 is related to invasion and poor prognosis in pancreatic cancer

Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3beta, 17beta-diol

Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules

Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export

SHOW MORE ARTICLES

Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis

Loss of RUNX3 expression by histone deacetylation is associated with biliary tract carcinogenesis

Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma

Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft

Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes

Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer

Antibody epitope peptides as potential inducers of IgG antibodies against CD98 oncoprotein

Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients

Gastric mucosal interleukin-17 and -18 mRNA expression inHelicobacter pylori-induced Mongolian gerbils

Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer

Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma